GW Pharmaceuticals PLC
They are a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform.
Last Closing Price
December 7, 2017
Goldman Sachs, Morgan Stanley, BofA Merrill Lynch, Cowen
To view the prospectus for GW Pharmaceuticals PLC, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277